News for Eliem Therapeutics, Inc (ELYM)

**media[546129]**

CLYM stock touches 52-week low at $1.86 amid market challenges

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement...

Name change to

Apparel retailer Stitch Fix, Inc. (SFIX), headquartered in California is down over 29 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Eliem Therapeutics shifted focus to autoimmune diseases with the acquisition of Tenet Medicines. Click here to read an analysis of ELYM stock now.

Eliem therapeutics executive sells over $9,000 in company stock

SEATTLE and CAMBRIDGE, United Kingdom, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced today members of the...

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Thursday. Shares of Build-A-Bear Workshop, Inc. BBW rose sharply during Thursday...

Brett Kaplan, M.D. appointed Chief Operating Officer Nishi Rampal, M.D. appointed Senior Vice President, Clinical Development SEATTLE and CAMBRIDGE,...

Eliem Therapeutics just reported results for the second quarter of 2024.

Eliem completed the acquisition of Tenet Medicines and concurrent $120 million private placement Eliem to host an Investor Day later in the year to...

Eliem Therapeutics EVP sells $338,000 in stock

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

Kuehn Law investigates INRD, AIRC, ELYM, ALPN mergers. Shareholders urged to contact for legal assistance....

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94. The S&P 500 also rose, gaining, 0.17% to 5,169.21.

Connecticut-based Rallybio Corporation (RLYB), a clinical-stage biotechnology company is up over 90 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Connecticut-based Rallybio Corporation (RLYB), a clinical-stage biotechnology company is up over 90 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.